Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review.

Rituxan (rituximab) - Roche

Orencia (abatacept) - BMS

http://www.ncbi.nlm.nih.gov/pubmed/42719119

Ana Valeria Acosta-Alfaro; Gabriela Nataly Cueva-Nájera; Isabel De La Cámara-Fernández; Olga María Reillo-Sánchez; Santiago Muñoz-Fernández; Tatiana Cobo-Ibáñez

Sep 11, 2026